Team
Our passionate team comprises healthcare professionals, researchers, Long COVID survivors, and advocates united by a common mission: to support recovery and enhance the quality of life for those affected by Long COVID. Together, we blend medical expertise, lived experience, and empathy to foster understanding, promote effective treatments, and build a supportive community.
Ivan Belyanov
Robert Tupikas
Robert Tupikas is a 23-year-old master’s student in Systems Biology and a bachelor of Genetics from Lithuania and co-founded Recover Long COVID with his close friend Ivan. Robert has dedicated himself to decoding the complexities of Long COVID. With his strong scientific background and relentless curiosity, Robert thoroughly analyzes and distills the latest scientific research into easy-to-understand insights—especially for patients experiencing brain fog or cognitive difficulties. His goal is to make the most critical discoveries and treatment advances accessible to all, no matter their cognitive state, empowering patients with clarity, support, and direction.
Prof. Dr. Mannan Baig
Scientific Advisor – Pioneering Research in COVID-19 and Long COVID
Dr. Abdul Mannan Baig stands at the forefront of COVID-19 and Long-COVID research, bringing distinguished expertise as a Senior Scientist and Medical Doctor to the global scientific community. He combines clinical insight with cutting-edge research to unravel the complexities of SARS-CoV-2 and its long-term effects, earning over 2,540 citations for his groundbreaking work in just three years.
Advancing Understanding Through Independent Research and Consultation
Through his NIH collaboration in drug discovery for neurological disorders, Dr. Baig extends his expertise beyond traditional boundaries, focusing on the neurological implications of COVID-19 and innovative drug repurposing strategies. His pioneering work includes novel approaches to apheresis in Long COVID and related chronic illnesses, alongside in-depth studies into the neurological deficits observed in COVID-19 patients.
Through consultancy and advanced lab research, Dr. Baig offers invaluable guidance to researchers and healthcare providers while maintaining active collaborations with prestigious institutions, including the US National Institutes of Health. His commitment stems from both scientific curiosity and a deep dedication to solving this emerging global health challenge, making him a leading expert in the field of post-viral complications and neurodegenerative conditions.
Dr. Baig is currently establishing a dedicated Long COVID laboratory in Cyprus, where he aims to identify critical biomarkers associated with the condition and contribute to the development of an effective cure. This lab will serve as a hub for innovation, diagnostics, and advanced research, accelerating the path toward recovery for countless patients worldwide.